Li N, Liu J, Deng X. Identification of a novel circRNA, hsa_circ_0065898, that regulates tumor growth in cervical squamous cell carcinoma. Transl Cancer Res. 2021;10(1):47–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu M, Ji H, Li K, Liu H, Peng M, Wang Z, et al. Investigating the potential mechanism of quercetin against cervical cancer. Discov Oncol. 2023;14(1):170.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakisige C, Trawin J, Mitchell-Foster S, Payne BA, Rawat A, Mithani N, et al. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol. BMC Public Health. 2020;20(1):142.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Qu H, Ma X, Liu X. Identification of oxidative stress-associated molecular subtypes and signature for predicting survival outcome of cervical squamous cell carcinoma. Oxid Med Cell Longev. 2022;2022:1056825.

PubMed  PubMed Central  Google Scholar 

Tian Y, Qi P, Niu Q, Hu X. Combined snail and E-cadherin predicts overall survival of cervical carcinoma patients: comparison among various epithelial-mesenchymal transition proteins. Front Mol Biosci. 2020;7:22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang A, Jiang A, Gan X, Wang Z, Huang J, Dong K, et al. EGFR-AS1 promotes bladder cancer progression by upregulating EGFR. Biomed Res Int. 2020;2020:6665974.

Article  PubMed  PubMed Central  Google Scholar 

Fang D, Ou X, Sun K, Zhou X, Li Y, Shi P, et al. m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 2022;113(12):4135–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao HL, Liu ZJ, Huang PL, Yue YL, Xi JN. lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206. Eur Rev Med Pharmacol Sci. 2019;23(3):1012–21.

PubMed  Google Scholar 

Zong S, Dai W, Guo X, Wang K. LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis. Aging (Albany NY). 2021;13(19):23169–81.

Article  CAS  PubMed  Google Scholar 

Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019;20(22):5758.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren X, Zhu H, Deng K, Ning X, Li L, Liu D, et al. Long noncoding RNA TPRG1-AS1 suppresses migration of vascular smooth muscle cells and attenuates atherogenesis via interacting with MYH9 protein. Arterioscler Thromb Vasc Biol. 2022;42(11):1378–97.

Article  CAS  PubMed  Google Scholar 

Choi JH, Kwon SM, Moon SU, Yoon S, Shah M, Lee BG, et al. TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659. Liver Int. 2021;41(11):2788–800.

Article  CAS  PubMed  Google Scholar 

He J, Dong C, Zhang H, Jiang Y, Liu T, Man X. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis. Cell Signal. 2023;102:110527.

Article  CAS  PubMed  Google Scholar 

Li Z, Qiu X, He Q, Fu X, Ji F, Tian X. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363–3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma. Sci Rep. 2023;13(1):11831.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong Z, Li Y, Chen M, Chen X, Deng X, Wu Y, et al. Protosappanin B enhances the chemosensitivity of 5-fluorouracil in colon adenocarcinoma by regulating the LINC00612/microRNA-590-3p/Golgi phosphoprotein 3 axis. Discov Oncol. 2024;15(1):193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan Z, Li X, Luo X, Wang B, Zhou X, Chen A. The miR-590–3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma. Aging (Albany NY). 2022;14(14):5783–99.

Article  CAS  PubMed  Google Scholar 

Shi X, Sheng W, Jia C, Tang J, Dong M. Hsa-MiR-590-3p promotes the malignancy progression of pancreatic ductal carcinoma by inhibiting the expression of p27 and PPP2R2A via G1/S cell cycle pathway. Onco Targets Ther. 2020;13:11045–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song TT, Xu F, Wang W. Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma. Kaohsiung J Med Sci. 2020;36(7):501–7.

Article  CAS  PubMed  Google Scholar 

Yu CL, Xu XL, Yuan F. LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer. Biosci Rep. 2019;39(9):BSR20190903.

Article  PubMed  PubMed Central  Google Scholar 

Arip M, Tan LF, Jayaraj R, Abdullah M, Rajagopal M, Selvaraja M. Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review. Discov Oncol. 2022;13(1):91.

Article  PubMed  PubMed Central  Google Scholar 

Šarenac T, Mikov M. Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this disease. Front Pharmacol. 2019;10:484.

Article  PubMed  PubMed Central  Google Scholar 

Zheng X, Gu H, Cao X, Pan B, Xiang H, Ju M, et al. Tislelizumab for cervical cancer: a retrospective study and analysis of correlative blood biomarkers. Front Immunol. 2023;14:1113369.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giannini A, Di Donato V, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, et al. Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines (Basel). 2023;11(3):698.

Article  PubMed  Google Scholar 

She S, Zhao Y, Kang B, Chen C, Chen X, Zhang X, et al. Combined inhibition of JAK1/2 and DNMT1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells. Cell Death Dis. 2020;11(9):724.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng Y, Hu H, Xiao L, Cai T, Gao W, Zhu H, et al. Identification of EMT-related lncRNAs as potential prognostic biomarkers and therapeutic targets for pancreatic adenocarcinoma. J Oncol. 2022;2022:8259951.

Article  PubMed  PubMed Central  Google Scholar 

Hao L, Wu W, Xu Y, Chen Y, Meng C, Yun J, et al. LncRNA-MALAT1: a key participant in the occurrence and development of cancer. Molecules. 2023;28(5):2126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu L, Yang X, Zhu R, Yu L. Identifying discriminative biological function features and rules for cancer-related long non-coding RNAs. Front Genet. 2020;11:598773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tachiwana H, Saitoh N. Nuclear long non-coding RNAs as epigenetic regulators in cancer. Curr Med Chem. 2021;28(25):5098–109.

Article  CAS  PubMed  Google Scholar 

Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–63.

Article  CAS  PubMed  PubMed Central